• <ul id="qe0qg"></ul>
    <ul id="qe0qg"><sup id="qe0qg"></sup></ul>
  • <fieldset id="qe0qg"><menu id="qe0qg"></menu></fieldset>
  • <strike id="qe0qg"></strike>
  • <ul id="qe0qg"></ul>
    <strike id="qe0qg"></strike>
    豪森藥業
    • Overview
    • 1995 Initial establishment
      A principal subsidiary of Hansoh Pharma (03692.HK)
      7
      Launched innovative drugs
      Top 100
      Pharmaceutical companies worldwide
      Top 3
      China's best Industrial enterprises in pharmaceutical R&D pipeline

    Therapy Areas

    • Anti-tumor
      Anti-tumor
      Anti-tumor
      Anti-tumor
      Anti-tumor
      Anti-tumor
      We focus on the develoment of new drugs in the field of common and hostile cancers.Our innovative medicine programs in clinical trials include HS-20106 injection, HS-20105 injection, HS-20117 injection, HS-10516 capsules, HS-10382 tablets, HS-10370 tablets, HS-10502 tablets, HS-10365 capsules, HS-20089 injection, HS-20093 injection, HS-10352 tablets, HS-10241 tablets, etc.
      More +
    • Anti-infectives
      Anti-infectives
      Anti-infectives
      Anti-infectives
      Anti-infectives
      Anti-infectives
      We focus on the development of new drugs in the fields of antiviral, anti-complex bacterial infection and anti-fungal infection. Our innovative medicine programs in clinical trials includeCitric Acid Erythorbate tablets, etc.
      More +
    • CNS Diseases
      CNS Diseases
      CNS Diseases
      CNS Diseases
      CNS Diseases
      CNS Diseases
      We focus on the development of new drugs in the fields of psychiatric and neurological disorders.Our innovative medicine programs in clinical trials include HS-10380 tablets, HS-10506 tablets, HS-10353 capsules, HS-10509 tablets, etc.
      More +
    • Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      Metabolic Diseases
      We focus on the development of new drugs in the field of metabolic diseases such as diabetes and obesity. Our innovative medicine programs in clinical trials include HS-10511 tablets, HS-20094 injection, HS-10384 tablets, HS-10518 capsules, HS-10390 tablets, HS-10501 tablets, and HS-10398 capsules, etc.
      More +
    • Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      Autoimmune Diseases
      We focus on the development of new drugs in the field of autoimmune diseases. Our innovative medicine programs in clinical trials includeHS-10374 tablets etc.
      More +
    R&D
    Innovation
    Jiangsu Hansoh Pharma Research Institute
    Jiangsu Hansoh Pharma Research Institute
    More
    Jiangsu Hansoh Pharma Administrative R&D Center
    Jiangsu Hansoh Pharma Administrative R&D Center
    More
    • Substantial investment on R&D
      In the first half of 2024, R&D investments increased by 28.7% year-on-year, accounting for 18.4% of the revenue
    • Competitive R&D pipeline
      Over 50 clinical studies for 30 innovative drugs at different clinical development stages.
    • Highly efficient capability to discover innovative drugs
      The R&D pipeline covers peptides , small molecules, biologics, ADC drugs, siRNAs, and more.
    A broader world, let's discover together
    Join Hansoh Pharma +
    Work with us
    We welcome talents worldwide to join us with their entrepreneurship and achieve new levels of success in their career!
    Join Hansoh Pharma +
    主站蜘蛛池模板: 蜜臀久久99精品久久久久久小说 | 亚洲av永久无码精品网站| 国产精品爽爽ⅴa在线观看| 国产精品国产AV片国产| 精品国产污污免费网站入口| 亚洲AV日韩精品久久久久| 九九热在线视频观看这里只有精品| 久久精品国产久精国产思思| 国产亚洲精品精华液| 九九99精品久久久久久| 国产在线精品一区二区高清不卡| 久久久久亚洲精品无码网址| 午夜欧美精品久久久久久久| 精品四虎免费观看国产高清午夜 | 蜜桃麻豆www久久国产精品| 亚洲日韩中文在线精品第一| 国产亚洲精品自在久久| MM1313亚洲精品无码| 野狼第一精品社区| 国产精品久久久久无码av| 国产三级精品三级在线观看专1 | 久久99久久99小草精品免视看| 国产精品久久久天天影视香蕉 | 亚洲国产精品无码中文字| 99热亚洲色精品国产88| 国产精品区AV一区二区| 精品一区二区三区免费毛片爱| 国产精品VIDEOSSEX久久发布| 无码精品黑人一区二区三区| 97精品在线播放| 精品人妻人人做人人爽 | 亚洲精品在线观看视频| 亚洲国产精品成人久久| 国产成人高清精品一区二区三区 | 亚洲av成人无码久久精品 | 无码aⅴ精品一区二区三区浪潮 | 国产精品自产拍在线观看花钱看| 亚洲精品无码久久毛片| 国产精品久操视频| 欧美精品国产一区二区| 精品乱码一区二区三区四区|